- Home
- SRPT
as 08-15-2025 11:42am EST
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 1.7B | IPO Year: | 1997 |
| Target Price: | $46.15 | AVG Volume (30 days): | 22.8M |
| Analyst Decision: | Hold | Number of Analysts: | 29 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.41 - $144.22 | Next Earning Date: | 08-06-2025 |
| Revenue: | $2,481,531,000 | Revenue Growth: | 64.89% |
| Revenue Growth (this year): | 3.52% | Revenue Growth (next year): | -26.05% |
Latest Sarepta Therapeutics Inc. (DE) News
SRPT Breaking Stock News: Dive into SRPT Ticker-Specific Updates for Smart Investing
Motley Fool
2 months ago
2 Beaten-Down Stocks to Avoid
Simply Wall St.
2 months ago
Sarepta Therapeutics (NasdaqGS:SRPT) Faces Shipment Suspension Amid Safety Update
Investor's Business Daily
2 months ago
Sarepta Therapeutics Is Already Down 86% This Year. And The Other Shoe Just Dropped.
Insider Monkey
2 months ago
TD Cowen Downgrades Sarepta Therapeutics (SRPT) Stock to Hold, Reduces PT
MT Newswires
2 months ago
Sarepta Therapeutics' Elevidys Under Investigation by US FDA Following Patient Deaths
Argus Research
2 months ago
SRPT: Lowering target price to $15.00
Insider Monkey
2 months ago
Sarepta Viral Vector Gets FDA Platform Technology Designation
Insider Monkey
2 months ago
Sarepta Therapeutics (SRPT) Tumbles 44% W/W as Analyst Cuts Price Target by 63%
Compare SRPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRPT Sarepta Therapeutics Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.